1.原文连结(必须检附)： http://reut.rs/1GqIacs
2.原文内容：
The United States and Australia have reached a compromise on the
length of monopoly protection allowed for new biotech drugs in a
development that could clear the way for a sweeping Pacific Rim
trade deal, Japanese media reported on Sunday.
日本媒体报道，美国与澳洲就生科新药专利保护期达成妥协，可望为TPP铺平
道路。
The amount of time allowed for pharmaceutical companies to have
exclusive rights to the clinical data for biological drugs has been
the last major sticking point in the Trans-Pacific Partnership
talks in Atlanta.
新药的临床数据保护期是TPP谈判中最后一个主要节点。
The compromise under discussion would grant a data exclusivity
period that would be eight years, in effect, Kyodo reported. That
would be in line with a U.S. proposal from last week. Reuters
could not immediately confirm the report.
共同社报道，正在谈判中的数据保护期事实上为8年，与美国上周的提案
相符。路透无法立即验证此报导
3.心得/评论(必需填写)：
TPP最后的堡垒有三个
1. 汽车原产地规则，已妥协为50%左右(日本与墨西哥，加拿大)
2. 乳制品开放，新西兰已承诺让步（新西兰与加拿大，美国，日本）
3. 生科药物专利保护期，看起来澳洲已经放弃了5年的要求，让步于美国
TPP明日有望达成